199003-62-8

Upstream product

• 14042-37-6 9-(2',3'-O-benzylidene-β-D-ribofuranosyl)guanine 
• 199003-54-8 N,N-diphenylmethylformamide dimethyl acetal 
• 118-00-3 G 
• 100-52-7 benzaldehyde 

Downstream Products

• 206852-90-6 Acetic acid (3aR,4R,6R,6aR)-6-[2-(dibenzylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester 
• 206852-94-0 C₆₆H₆₈N₁₀O₁₂P₂ 
• 206852-93-9 N'-[1-{2-[2-(2-Azido-ethoxy)-ethoxy]-ethyl}-9-((3aR,4R,6R,6aR)-6-hydroxymethyl-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-N,N-dibenzyl-formamidine 
• 206852-91-7 Acetic acid (3aR,4R,6R,6aR)-6-[1-{2-[2-(2-azido-ethoxy)-ethoxy]-ethyl}-2-(dibenzylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester 

Relevant academic research and scientific papers

Synthesis of a functionalized GDP-analogue designed for anti-GDP antibody production

An enzymatically stable analogue of GDP is prepared in 7 steps starting from guanosine. The guanine moiety is functionalized at the N-1 position so as to allow anchoring of the nucleotide onto a carrier protein for subsequent immunization of animals in order to raise antibodies against GDP.